This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1993 Jul 1;70(1):204-7.

Low molecular weight heparin

J Hirsh¹

Affiliations

PMID: 8236105

Review

Low molecular weight heparin

J Hirsh. Thromb Haemost. 1993.

. 1993 Jul 1;70(1):204-7.

Author

J Hirsh¹

Affiliation

¹ McMaster University, Hamilton, Ontario, Canada.

PMID: 8236105

No abstract available

PubMed Disclaimer

Similar articles

Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA. Mousa SA. Curr Opin Investig Drugs. 2002 Aug;3(8):1181-6. Curr Opin Investig Drugs. 2002. PMID: 12211411 Review.
Heparin and low-molecular-weight heparin.
Gray E, Mulloy B, Barrowcliffe TW. Gray E, et al. Thromb Haemost. 2008 May;99(5):807-18. doi: 10.1160/TH08-01-0032. Thromb Haemost. 2008. PMID: 18449410 Review.
Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
Mousa SA, Fareed J. Mousa SA, et al. Curr Opin Investig Drugs. 2001 Aug;2(8):1077-80. Curr Opin Investig Drugs. 2001. PMID: 11892916 Review. No abstract available.
[Standard heparin and low molecular weight heparins].
Chojnowski K, Judkiewicz L, Sobol A. Chojnowski K, et al. Acta Haematol Pol. 1992;23(4):207-12. Acta Haematol Pol. 1992. PMID: 1338174 Polish. No abstract available.
Advantages of low molecular weight heparin over standard heparin: facts and fiction.
Vinazzer H. Vinazzer H. Semin Thromb Hemost. 1991 Oct;17(4):385-8. doi: 10.1055/s-2007-1002640. Semin Thromb Hemost. 1991. PMID: 1666459 Clinical Trial. No abstract available.

See all similar articles

Cited by

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA. Kahale LA, et al. Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650. doi: 10.1002/14651858.CD006650.pub5. Cochrane Database Syst Rev. 2018. PMID: 29920657 Free PMC article.
Parenteral anticoagulation in ambulatory patients with cancer.
Akl EA, Kahale LA, Hakoum MB, Matar CF, Sperati F, Barba M, Yosuico VED, Terrenato I, Synnot A, Schünemann H. Akl EA, et al. Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD006652. doi: 10.1002/14651858.CD006652.pub5. Cochrane Database Syst Rev. 2017. PMID: 28892556 Free PMC article.
Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.
Mukherjee AK, Chattopadhyay DJ. Mukherjee AK, et al. Phytother Res. 2022 May;36(5):1884-1913. doi: 10.1002/ptr.7408. Epub 2022 Feb 11. Phytother Res. 2022. PMID: 35147268 Free PMC article. Review.
Prophylaxis for venous thromboembolism in hip fracture surgery: total costs and cost effectiveness in The Netherlands.
Mol WE, Egberts TC. Mol WE, et al. Pharmacoeconomics. 1994 Jan;5(1):48-55. doi: 10.2165/00019053-199405010-00007. Pharmacoeconomics. 1994. PMID: 10146866
[Heparin-induced thrombocytopenia with unfractionated heparin. A prospective study of inpatient treatment of internal medicine patients].
Heidrich H, Kahl K, Penninger C, Bechstein B, Birkenmaier M, Dressler S, Fahrig C, Helmis J, Herman G, von Knobloch U, Ladleif M, Meier K, Rudolph M, Schlich B, Wanke M, Zwernemann B. Heidrich H, et al. Med Klin (Munich). 1998 Jun 15;93(6):343-6. doi: 10.1007/BF03044677. Med Klin (Munich). 1998. PMID: 9662940 German.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information